Chart - you can draw at the chart
Starting Amount
$
After
years
Dividend yield
%
Dividends reinvested
$
ZIOPHARM Oncology, Inc.
Type
Public
Traded as NASDAQ: ZIOP
Industry Biotechnology
Headquarters Boston, Massachusetts
Key people
Laurence J. N. Cooper, M.D., Ph.D. (CEO)
Caesar J. Belbel (COO)
Sir Murray Brennan
Randal J. Kirk (Director)
Website ZIOPHARM.com

ZIOPHARM Oncology is a publicly held, clinical-stage biopharmaceutical company headquartered in Boston, Massachusetts, that develops novel immunotherapies for the treatment of cancer.

In 2011, ZIOPHARM established a partnership with Intrexon Corporation to develop and commercialize DNA-based cancer drugs based on Intrexon's synthetic biology technology platform.

ZIOPHARM has two oncology therapeutics in clinical development, IL-12 DNA and CD-19-Sleeping Beauty Cells, and expects to initiate five additional CAR-T cell therapy clinical programs in 2015.


Investment goal date:
Dividends reinvested
ZIOPHARM Oncology, Inc. ZIOP report Q3 2017
Period
Date
Adjusted Actuals EPS
GAAP EPS
Q1 2018
2018-05-07
--
--
Q4 2017
2018-02-22
--
--
Q4 2017
2018-02-20
--
--
Q3 2017
2017-11-06
--
--
Q3 2017
2017-11-06
-0.1300
0.0000
Q2 2017
2017-07-31
-0.1300
-0.1300
Q1 2017
2017-05-01
-0.1500
-0.1500
Q4 2016
2017-02-16
-0.1100
-0.1100
Q3 2016
2016-11-09
-0.1100
-0.1100
Q2 2016
2016-08-09
-1.0100
-1.0100
Q1 2016
2016-05-10
-0.0900
-0.0900
Q4 2015
2016-02-24
-0.0700
-0.0700
Q3 2015
2015-11-02
-0.1400
-0.1400
There is presents forecasts or rating agencies and recommendation for investors about this ticker
Funds
Fund Name
Ticker shares
BANK OF AMERICA CORP /DE/
864802
Bank of New York Mellon Corp
598406
BlackRock Fund Advisors
3621895
BlackRock Inc.
7542908
BlackRock Institutional Trust Company, N.A.
3104916
GEODE CAPITAL MANAGEMENT, LLC
1016427
Invesco Ltd.
1050018
LMM LLC
4925321
MORGAN STANLEY
1989175
MSDC Management, L.P.
3410500
NORTHERN TRUST CORP
1481791
STATE STREET CORP
4039207
Third Security, LLC
9709607
UBS Group AG
730291
Vanguard Group, Inc
7310537
Major Shareholders
Name Relationship
Total Shares
Holding stocks
LEBEL FRANCOIS
0.1400% (137683)
ZIOP /
KIRK RANDAL J
0.1400% (139513)
BELBEL CAESAR J
0.1700% (173551)
ZIOP /
WEISER MICHAEL
0.2000% (205370)
CHTP / EMIS / TGTX / ZIOP /
MCINERNEY TIMOTHY
0.3700% (372120)
EMIS / TGTX / ZIOP /
ESSEX WOODLANDS HEALTH VENTURES FUND VI L P
2.3500% (2371642)
LJPC / ZIOP /
Fowler Wyche
0.1400% (141870)
BDN / ZIOP /
MAUNEY DAVID M MD
0.0600% (58662)
ZIOP /
LEWIS JONATHAN
0.7400% (744145)
ZIOP /
CANNON JAMES ANTHONY
0.3600% (367502)
ZIOP /
FRAGIN GARY S
0.0700% (67500)
ZIOP /
BRENNAN MURRAY
0.0500% (54814)
ZIOP /
BAGLEY RICHARD E
0.2100% (211239)
ZIOP /
Lafond Kevin G
0.0600% (57967)
ZIOP /
Amello Jason
0.0200% (22377)
AKBA / OPXA / ZIOP /
ABERCROMBIE GEORGE B
0.0200% (25000)
BCRX / OCRX / THRX / ZIOP /
Youssoufian Hagop
0.0900% (92721)
BIND / PGNX / ZIOP /
Cooper Laurence James Neil
1.0700% (1077291)
ZIOP /
% ()